Radical Cystectomy vs Trimodality Therapy in Bladder Cancer: Propensity Score Analysis | CRSF 2024 скачать в хорошем качестве

Radical Cystectomy vs Trimodality Therapy in Bladder Cancer: Propensity Score Analysis | CRSF 2024

Join us for an in-depth session on muscle-invasive bladder cancer at Day 2 of the Cancer Research and Statistic Foundation's 05th Knowledge Series for Genitourinary Cancers - Best of 2023, held on 12th May, 2024 at The Pride Aero City Delhi. Supported by the Institute of Pulmonology Medical Research & Development and Sunrise Oncology Centre, this session brings together leading experts in cancer treatment. Dr. Saurabh Patil from Mumbai presents a multi-institutional propensity score matched and weighted analysis comparing Radical Cystectomy and Trimodality Therapy for muscle-invasive bladder cancer. This highly anticipated study evaluates the oncological outcomes of these two treatment modalities, providing valuable insights for practitioners seeking optimal therapeutic strategies for bladder cancer patients. Key Insights Covered: Radical Cystectomy: A surgical procedure to remove the bladder and surrounding tissues in patients with muscle-invasive bladder cancer. Trimodality Therapy (TMT): A combination of chemotherapy, radiation therapy, and bladder preservation techniques, offering an alternative to radical surgery. Propensity Score Matched & Weighted Analysis: An in-depth analysis comparing the outcomes of radical cystectomy versus TMT across multiple institutions, balancing patient characteristics and providing a clearer understanding of the benefits and risks of each approach. Survival Rates & Quality of Life: Dr. Patil presents crucial data on overall survival, cancer-specific survival, recurrence, and post-treatment quality of life, helping professionals determine the most suitable approach for their patients. This session is essential viewing for urologists, oncologists, cancer researchers, and healthcare professionals interested in the evolving landscape of bladder cancer treatment. It is also valuable for patients and caregivers looking for the latest information on treatment options for muscle-invasive bladder cancer. About Cancer Research and Statistic Foundation (CRS): The CRS Foundation is dedicated to advancing cancer research, improving treatment methodologies, and fostering collaboration among medical professionals. The 05th Knowledge Series brings together the Best of 2023 in genitourinary cancer treatment, with top experts sharing their latest findings and research. About the Supporting Institutes: Institute of Pulmonology Medical Research & Development: A research center dedicated to pulmonology and oncology advancements. Sunrise Oncology Centre: A premier oncology center providing cutting-edge cancer treatment and research. Don’t miss this critical session exploring two leading treatment options for muscle-invasive bladder cancer. For more updates on future sessions and research, subscribe to our channel and follow us on social media! #CancerResearch #BladderCancer #RadicalCystectomy #TrimodalityTherapy #BladderPreservation #MuscleInvasiveBladderCancer #CRSFoundation #GenitourinaryCancers #CancerTreatment #OncologyResearch #MedicalConference2024 #SunriseOncologyCentre #InstituteOfPulmonology